Showing results (531-540 of 552) with videos related to
Sort By:
Pageof 56
Viruses|March 12, 2020
Immunization of Cats against Fel d 1 Results in Reduced Allergic Symptoms of OwnersFranziska Thoms, Stefanie Haas, Aline Erhart, et al.Vaccines|September 28, 2024
Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle VaccinesDominik A Rothen, Sudip Kumar Dutta, Pascal S Krenger, et al.Frontiers in Immunology|June 4, 2019
Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-VaccineMona O Mohsen, Monique Vogel, Carsten Riether, et al.Diseases (Basel, Switzerland)|November 25, 2018
DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based VaccinesGustavo Cabral-Miranda, Ahmed M Salman, Mona O Mohsen, et al.Allergy|April 11, 2022
Intranasal administration of a virus like particles-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concernDominik A Rothen, Pascal S Krenger, Aleksandra Nonic, et al.Journal of Hypertension|December 5, 2006
A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicityPatrice M Ambühl, Alain C Tissot, Alma Fulurija, et al.Immunity|March 29, 2022
Secondary influenza challenge triggers resident memory B cell migration and rapid relocation to boost antibody secretion at infected sitesAndrew J MacLean, Niamh Richmond, Lada Koneva, et al.The Journal of Allergy and Clinical Immunology|December 24, 2019
Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergensFederico Storni, Andris Zeltins, Ina Balke, et al.Thrombosis and Haemostasis|May 3, 2013
Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart DiseaseR De Caterina, S Husted, L Wallentin, et al.Allergy|March 8, 2023
The next generation virus-like particle platform for the treatment of peanut allergyJan M Sobczak, Pascal S Krenger, Federico Storni, et al.Pageof 56